| # | Title | Journal | Year | Citations |
|---|
| 1 | Frequent neurocognitive deficits after recovery from mild COVID-19 | Brain Communications | 2020 | 236 |
| 2 | The orbitofrontal cortex: reward, emotion and depression | Brain Communications | 2020 | 169 |
| 3 | The cognitive consequences of the COVID-19 epidemic: collateral damage? | Brain Communications | 2020 | 151 |
| 4 | Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis | Brain Communications | 2022 | 147 |
| 5 | Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes | Brain Communications | 2020 | 98 |
| 6 | The role of the medial prefrontal cortex in cognition, ageing and dementia | Brain Communications | 2021 | 97 |
| 7 | Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes | Brain Communications | 2020 | 81 |
| 8 | Rapid vigilance and episodic memory decrements in COVID-19 survivors | Brain Communications | 2022 | 72 |
| 9 | Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention | Brain Communications | 2020 | 69 |
| 10 | Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk | Brain Communications | 2019 | 67 |
| 11 | Circadian and multiday seizure periodicities, and seizure clusters in canine epilepsy | Brain Communications | 2020 | 63 |
| 12 | Neuroimaging in Parkinson’s disease dementia: connecting the dots | Brain Communications | 2019 | 62 |
| 13 | Mechanical property alterations across the cerebral cortex due to Alzheimer’s disease | Brain Communications | 2020 | 57 |
| 14 | Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years | Brain Communications | 2022 | 57 |
| 15 | TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients | Brain Communications | 2020 | 55 |
| 16 | Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosis | Brain Communications | 2020 | 55 |
| 17 | Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses | Brain Communications | 2020 | 53 |
| 18 | Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivity | Brain Communications | 2020 | 53 |
| 19 | Epilepsy in the mTORopathies: opportunities for precision medicine | Brain Communications | 2021 | 53 |
| 20 | Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate? | Brain Communications | 2020 | 52 |
| 21 | White matter hyperintensities are common in midlife and already associated with cognitive decline | Brain Communications | 2019 | 51 |
| 22 | Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy | Brain Communications | 2020 | 51 |
| 23 | Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers | Brain Communications | 2021 | 51 |
| 24 | Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development | Brain Communications | 2019 | 49 |
| 25 | Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansion | Brain Communications | 2020 | 48 |
| 26 | Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study | Brain Communications | 2021 | 48 |
| 27 | Cerebrovascular disease promotes tau pathology in Alzheimer’s disease | Brain Communications | 2020 | 46 |
| 28 | 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial | Brain Communications | 2020 | 46 |
| 29 | Increased weighting on prior knowledge in Lewy body-associated visual hallucinations | Brain Communications | 2019 | 45 |
| 30 | Objective interictal electrophysiology biomarkers optimize prediction of epilepsy surgery outcome | Brain Communications | 2021 | 45 |
| 31 | A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE | Brain Communications | 2020 | 45 |
| 32 | Current knowledge of SLC6A1-related neurodevelopmental disorders | Brain Communications | 2020 | 44 |
| 33 | Genome-wide association studies for Alzheimer’s disease: bigger is not always better | Brain Communications | 2022 | 44 |
| 34 | Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes | Brain Communications | 2021 | 43 |
| 35 | Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers | Brain Communications | 2019 | 42 |
| 36 | Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain | Brain Communications | 2021 | 42 |
| 37 | Quantifying bias in psychological and physical health in the UK Biobank imaging sub-sample | Brain Communications | 2022 | 42 |
| 38 | Artificial intelligence for clinical decision support in neurology | Brain Communications | 2020 | 41 |
| 39 | High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display | Brain Communications | 2020 | 41 |
| 40 | Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor | Brain Communications | 2021 | 41 |
| 41 | Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma | Brain Communications | 2019 | 40 |
| 42 | Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin | Brain Communications | 2020 | 39 |
| 43 | Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis | Brain Communications | 2021 | 39 |
| 44 | Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition | Brain Communications | 2021 | 38 |
| 45 | Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau | Brain Communications | 2020 | 37 |
| 46 | Acetyl-leucine slows disease progression in lysosomal storage disorders | Brain Communications | 2021 | 37 |
| 47 | Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies | Brain Communications | 2021 | 37 |
| 48 | Midbrain organoids with anSNCAgene triplication model key features of synucleinopathy | Brain Communications | 2021 | 37 |
| 49 | Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies | Brain Communications | 2021 | 36 |
| 50 | Chronic subthreshold cortical stimulation and stimulation-related EEG biomarkers for focal epilepsy | Brain Communications | 2019 | 35 |
